Founded Date: 2020-01-01
Total Funding: 120000.0
Employee Number: 1-10
Funding Status: Seed
Technology: Immunotherapy
Last Funding Type: Pre-Seed
Investors Number: 1.0
Last Funding Date: 2020-01-17
Industry: Early Drug Development
Headquarters: Boston, Massachusetts, United States
Estimated Revenue: $1M to $10M